drugset / Trial / NCT01394991
A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety of epoetin alfa in patients with cancer who have chemotherapy-related anemia.
Timeline
- Start
- 2006-01
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 150 iu/kg | Subcutaneous |
| Subject | epoetin alfa | Protein / enzyme biologic | 450 iu/kg | Subcutaneous |